Salivary EGF concentration in adults with chronic laryngitis caused by laryngopharyngeal reflux;Estudo da concentração salivar do fator de crescimento epidérmico em indivíduos com laringite crônica por refluxo laringofaríngeo

Revista Brasileira de Otorrinolaringologia

Volumn 69, Issue 5, 2003, Pages 590-597

  Eckley, Claudia A ^a,b,d   Costa, Henrique O ^b,c  

^a Fac Cie Med da Santa Casa de SP   (Brazil)

^b FCMSCSP   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d NONE   (Brazil)

Author keywords

Epidermal growth factor; Gastroesophageal reflux disease; Reflux laryngitis; Saliva

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; AGED; ARTICLE; CELL MATURATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; ESOPHAGUS MANOMETRY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INFLAMMATION; LARYNGITIS; LARYNGOPHARYNGEAL REFLUX; MALE; PATHOGENESIS; PEPTIDE ANALYSIS; PH MEASUREMENT; REFLUX ESOPHAGITIS; SALIVA LEVEL; STATISTICAL SIGNIFICANCE; STOMACH ACID SECRETION; SYMPTOMATOLOGY; WOUND HEALING;

EID: 4644304909     PISSN: 00347299     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-72992003000500002     Document Type: Article

References (25)

1. Johnason JF. Epidemiology of esophageal and supraesophageal injuries. Am J Med 2000; 108(4A):99S-103S.
2. Cherry J, Margulies S.I. Contact ulcer of the larynx. Laryngoscope 1968; 78:1937-40.
3. Costa HO, Eckley CA, Fernandes AMF, Destailleur D, Villela PH. Refluxo gastroesofágico: comparação entre achados laríngeos e digestivos. Rev Port ORL 1997; 35(1):21-6.
4. Eckley CA & Costa HO. Manifestaçóes Otorrinolaringológicas da Doença do Refluxo Gastroesofá gico. In: Martinez JC. Affecçóes Cirúrgicas do Estômago e Intestino Delgado. São Paulo: Atheneu; 2002. No prelo.
5. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101(Suppl):1-78.
6. Rourk RM, Namiot Z, Saroziek J, Yu Z, Mccallum RW. Impairment of Salivary Epidermal Growth Factor Secretory Response to Esophageal Mechanical and Chemical Stimulation in Patients with Reflux Esophagitis. Am J Gastroenterol 1994; 89(2):237-44.
7. Sonnenberg A, Steinkamp U, Weise A, Berges W, Weinbeck M, Rohner HG, Peter P. Salivary Secretion in Reflux Esophagitis. Gastroenterol 1982; 83:889-95.
8. Starkey RH. & Orth DN. Radioimmunoassay of human epidermal growth factor (urogastrone). J Clin Endocrinol Metab 1977; 45(6):1144-53.
9. Gray MR, Donneley RJ, Kingsnorth AN. Role of salivary epidermal growth factor in the pathogenisis of Barrett's columnar lined oesophagus. Br J Surg 1991; 78:1461-6.
10. Konturek JW, Bielanski W, Konturek SJ, Konturek JW, Oleksy J, Yamazaki J. Distribution and release of epidermal growth factor in man. Gut 1989; 30:1194-200.
11. Marcinkiewicz M, Han K, Zbroach T, Poplawski C, Gramley W, Goldin G, Sarosiek J. The Potential Role of the Esophageal Pre-Epithelial Barrier Components in the Maintenance of Integrity of the Esophageal Mucosa in Patients with Endoscopically Negative Gastroesophageal Reflux Disease. Am J Gastroenterol 2000; 95(7):1652-60.
12. Sarosiek J & Mccallum RW. Do salivary Organic Components Play a Protective Role in Health and Disease of the Esophageal Mucosa? Digestion 1995; 56 (Suppl. 1):32-7.
13. Sarosiek J, Scheurich CJ, Marcinkiewicz M, Mccallum R.W. Enhancement of Salivary Esophagoprotection: Rationale for a Physiological Approach to Gastroesophageal Reflux Disease. Am J Gastroenterol 1996; 110:675-81.
14. Itoh M, Joh T, Imai S, Miyamoto T, Matsusako K, Iwai A, Katsumi K, Endo K, Goto K, Takeuchi T. Experimental and clinical studies on epidermal growth factor for gastric mucosal protection and healing of gastric ulcers. J Clin Gastroenterol 1988; 10 (Suppl.1):S7-12.
15. Okita K, Karita M, Nakanishi N. Role of Epidermal Growth Factor in Protection and Repair of Gastric Mucosal Injury. J Clin Gastroenterol 1991; 13(Suppl.1):S103-8.
16. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962; 237(5):1555-62.
17. Anelli W. In: Aspectos perceptivos-auditivos e acústicos da Doença do Refluxo Gastroesofágico. São Paulo; 2002. p. 97. (Tese Mestrado - UNIFESP).
18. Moraes-Filho JPP, Cecconello I, Gama-Rodrigues J, Castro LP. Brazilian consensus on gastroesophageal reflux disease: proposals for assessment classification and management. Am J Gastroenterol 2002; 97(2):241-8.
19. Ronkainen JA, Aro P, Storskrubb T. Prevalence of esophagitis and endoscopy-negative reflux disease in a population. A report from the Kalixandra Study. Abstracts of the Digestive Disease Week 2002; S1357:A-269.
20. Helm JF, Dodds WJ, Hogan WJ. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterol 1987; 93:1393-7.
21. Olsen PS, Poulsen SS, Kirkegaard P, Nexo E. Role of Submandibular Saliva and Epidermal Growth Factor in Gastric Cytoprotection. Gastroenterol 1984; 87:103-8.
22. Dumbrigue HB, Sandow PL, Nguyen KT, et al. Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck. Oral Surg Oral Med Oral Pathol 2000; 89(6):710-6.
23. Korsten MA, Rosman AS, Fishbein S, Shlein RD, Goldberg HE, Biener A. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med 1991; 90:701-6.
24. Moazzez R, Anggiansah A, Bartlett D, Owen W. Tooth wear saliva and symptoms of GERD: is there a relationship? Abstracts of the Digestive Disease Week 2002 W1164:A-816.
25. Joh T, Itoh M, Katsumi K, Yokoyama Y, Takeuchi T, Kato T, Wada Y, Tanaka R. Physiolocical concentration of human epidermal growth factor in biological fluids: use of a sensitive enzyme immunoassay. Clin Chem Acta 1986; 158:81-90.